- Login
- Register & Subscribe
- Language: EN FR DE
Regenerative Medicine
ReNeuron receives clearance for stem cell trial
Wednesday 10 February 2010
Location
United Kingdom
The ReNeuron Group Plc has received final regulatory clearance to start its ground-breaking first-in-man study of a stem cell therapy for stroke. The therapy will be administered to patients who have been left disabled by an ischaemic stroke.
First patient treated in US stem cell trial
Friday 22 January 2010
Location
United States
A patient in the US has become the first person with the neurodegenerative disease, amyotrophic lateral sclerosis (ALS), to be treated with stem cells. The cells were directly injected into the spinal cord of the patient on 20 January 2010.
FDA puts hold on ACT trial
Sunday 10 January 2010
Location
United States
The US Food and Drug Administration has put a ‘clinical hold’ on a proposed first-in-man study of a new embryonic stem cell treatment for eye disease, according to the developer.
Cell Medica links up with US medical centre
Thursday 7 January 2010
Location
United Kingdom
Cell Medica Ltd of London, UK has signed a research and development agreement with a medical research center in Texas to help it commercialise clinically-proven cell therapies which have been pioneered by the US researchers.
UK researchers report successful treatment of eye disease with stem cells
Thursday 31 December 2009
Location
United Kingdom
Researchers at Newcastle University in the UK have reported the successful treatment of eight patients suffering from an eye disease known as limbal stem cell deficiency with the patients’ own stem cells. The treatment was administered in a clinical trial.
Geron sees trial start in 2010 third quarter
Wednesday 18 November 2009
Location
United States
Geron Corporation of Menlo Park California, US expects to begin its first-in-man study of a new embryonic stem cell therapy for spinal cord injury in the third quarter of 2010. This follows discussions with the Food and Drug Administration during which a strategy was outlined for lifting the trial hold.
TiGenix to acquire UK medical technology company for €16 million
Monday 16 November 2009
Location
Belgium
TiGenix NV of Belgium is set to acquire Orthomimetics, a privately-held UK medical technology company, for shares valued at €16 million in order to extend its regenerative medicines franchise.
UK regenerative medicines company receives £1.2 million
Tuesday 20 October 2009
Location
United Kingdom
BioCeramic Therapeutics, a privately-owned company that is developing bioactive materials for orthopaedic and dental applications has received £1.2 million to support its operations ahead of the commercialisation of its lead product in 2010.
Private equity group acquires stem cell company
Friday 2 October 2009
Location
Portugal
The Riverside Company, a private equity group with offices in Brussels, Belgium, has acquired Crioestaminal SA of Portugal which collects stem cells from umbilical cord blood.
Cell Medica receives £1.95 million to commercialise cell therapy
Monday 21 September 2009
Location
United Kingdom
Cell Medica Ltd, an early-stage cellular therapeutics company, has received £1.95 million in new funding in order to commercialise its lead product, a cell therapy technique which protects patients from infection following a bone marrow transplant.
Select a News Category
Recent Appointments
Svein Lien becomes CEO of Biotec Pharmacon
Wednesday March 10 2010
Catherine Bréchignac to join Sanofi-Aventis board
Monday March 8 2010
Ulf Jönsson joins PharmaDiagnostics
Monday March 8 2010
Jan van Heek appointed non-executive director at Amarin
Monday March 8 2010
Thomas Hecht to become chairman of Cytos Biotechnology
Monday March 8 2010